Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Keytruda 100mg Injection
Manufacturer/Marketed By : MSD PHARMACEUTICALS PVT LTD
$2221.06 $1865.69
Keytruda 100mg Injection is an immunotherapy medication containing the active constituent pembrolizumab. It is used to treat cancers in the skin, lungs, bladder, stomach, liver, gallbladder, cervix, kidney, colon, rectum,...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
PEMBROLIZUMAB
Active Pharmaceutical Ingredient
Keytruda 100mg Injection
2,221.06$
1,865.69$
Keytruda 100mg Injection is an immunotherapy medication containing the active constituent pembrolizumab. It is used to treat cancers in the skin, lungs, bladder, stomach, liver, gallbladder, cervix, kidney, colon, rectum, esophagus, breast, and uterus cancers. It is used to treat head and neck cancer and classical Hodgkin lymphoma (a type of blood cancer). Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. It can lead to durable responses and improved survival in some patients with advanced cancer. It can improve overall survival in patients with several types of advanced cancer. However, not all patients respond to it, and some may experience side effects. Keytruda 100mg Injection is not recommended for adolescents and children under 18 years of age, except for children with classical Hodgkin lymphoma aged three years and older. Use effective birth control during the treatment and for at least four months after the last dose. As with any cancer treatment, the decision to use it will depend on several factors, including the type and stage of cancer, the patient's overall health, and other treatments the patient has received. Patients should discuss the potential risks and benefits with their healthcare provider.
Active Pharmaceutical Ingredient
Uses
• Advanced melanoma
• Non-small cell lung cancer
• Classical Hodgkin lymphoma
• Urothelial carcinoma
• Gastric cancer
• Head and neck squamous cell carcinoma
• Cervical cancer
• Primary mediastinal large B-cell lymphoma
Benefits
The therapeutic effect of pembrolizumab is the activation of the immune system to identify and attack cancer cells in the body. It is a type of immunotherapy drug that blocks a protein called PD-1 present in immune cells, which allows the immune system to identify and attack cancer cells more effectively. By doing so, this drug can help slow or inhibit the spread and growth of cancer cells in the body.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Most Common Side Effects
• Fatigue
• Nausea
• Loss of appetite
• Diarrhea or constipation
• Skin rash or itching
• Headache
• Muscle or joint pain
• Cough or shortness of breath
• Fever or chills
• Low blood cell counts
Common Side Effects
• Pneumonitis (inflammation of the lungs).
• Hepatitis (inflammation of the liver).
• Colitis (inflammation of the colon).
• Hypothyroidism or hyperthyroidism.
• Adrenal insufficiency (decreased adrenal function).
• Type 1 diabetes.
How To Use
Keytruda 100mg Injection is a medication that is administered by a healthcare professional, typically in a hospital or clinic setting. The medication is given as an intravenous (IV) infusion. The dosage and frequency will depend on the type and stage of the cancer, as well as the patient's overall health and response to the medication. The medication is typically given every three to four weeks, and the number of treatment cycles varies with the type and staging of cancer and the patient's response to the drug. During the infusion, the patient will be monitored by a healthcare professional for any potential side effects or reactions to the medication.
Safety Advice
• Breast Feeding: If women is taking then it is a potential risk of harm to a nursing infant. Breastfeeding women should discuss the potential risks and benefits of the medication with their healthcare provider before starting treatment.
• Alcohol: It is generally recommended that patients taking Keytruda 100mg Injections avoid or limit their alcohol intake, as alcohol increases the risk of liver damage and exacerbates any liver-related side effects.
• Liver: Keytruda 100 mg Injection can affect liver function, and patients with pre-existing liver disease or abnormalities may be at increased risk of liver damage. Patients should tell their healthcare provider if they have a history of liver disease or abnormal liver function tests because it is unsafe to use this drug with pre-existing liver disease.
• Lungs: Keytruda 100mg Injection has been associated with mild lung-related side effects, although these are relatively uncommon. You should consult the doctor if you have any lung diseases before starting the treatment.
• Driving: Patients receiving Keytruda 100mg Injection should avoid driving or operating machinery if they experience side effects such as fatigue, dizziness, or blurred vision, impairing a patient's ability to drive or operate machinery safely.
• Pregnancy: Keytruda 100mg Injection is unsafe for a developing fetus, and it is not recommended for use during pregnancy.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.